Phase 1Recruiting
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine (Academic or other)
- Enrolment
- 86 planned
- Conditions
- Frailty
- Interventions
- AlloRx
- Ages
- children, adults, older adults
- Registry
- NCT05018767
From the registry
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Aging Frailty
Primary outcomes
- Safety (adverse events)